Head-to-Head Comparison of Sirolimus-and Paclitaxel-Eluting Stent in the Same Diabetic Patient With Multiple Coronary Artery Lesions : A prospective, randomized, multicenter study

It is still controversial whether sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) are equally effective in patients with diabetes. In these patients, multiple individual variables may be responsible for neointimal hyperplasia, thus making difficult the comparison of the two drug-elu...

Ausführliche Beschreibung